Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

Heerspink, Hiddo J. L.; Birkenfeld, Andreas L.; Cherney, David Z. I.; Colhoun, Helen M.; Ji, Linong; Mathieu, Chantal; Groop, Per-Henrik; Pratley, Richard E.; Rosas, Sylvia E.; Rossing, Peter; Skyler, Jay S.; Tuttle, Katherine R.; Lawatscheck, Robert; Scott, Charlie; Edfors, Robert; Scheerer, Markus F.; Kolkhof, Peter; McGill, Janet B.

Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial

Autor(en):

Heerspink, Hiddo J. L.; Birkenfeld, Andreas L.; Cherney, David Z. I.; Colhoun, Helen M.; Ji, Linong; Mathieu, Chantal; Groop, Per-Henrik; Pratley, Richard E.; Rosas, Sylvia E.; Rossing, Peter; Skyler, Jay S.; Tuttle, Katherine R.; Lawatscheck, Robert; Scott, Charlie; Edfors, Robert; Scheerer, Markus F.; Kolkhof, Peter; McGill, Janet B.

Tübinger Autor(en):

Birkenfeld, Andreas L.

Erschienen in:

Diabetes Research and Clinical Practice (2023), Bd. 204, Article 110908

Verlagsangabe:

Clare : Elsevier Ireland Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.diabres.2023.110908

ISSN:

0168-8227